EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus

Bengt Wahlin iD, Antje Braune, Elias Jönsson, Solveig Wållberg-Jonsson, Christine Bengtsson

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0312546 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Bengt Wahlin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Hydroxychloroquine, Glycated Hemoglobin, Arthritis, Rheumatoid, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hydroxychloroquine (HCQ) exerts a large reduction of cardiovascular risk in patients with inflammatory diseases, but the mechanisms are not fully known. The aim of this study was to study potential mechanisms for this.

Methods

This interventional study (EudraCT 2014-005418-45) in 30 patients (23 with rheumatoid arthritis, 7 with systemic lupus erythematosus) investigates the effects of HCQ on cardiovascular risk factors and arterial stiffness in patients with inflammatory disease. Blood lipids, blood pressure, blood glucose, glycated haemoglobin (HbA1c) and arterial stiffness was assessed at initiation, after four weeks of treatment and after eight weeks of treatment with 200 mg HCQ daily.

Results

After four weeks of treatment with HCQ, total cholesterol had decreased from 5.4 mmol/L to 5.1 mmol/L (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxychloroquineGlycated HemoglobinArthritis, RheumatoidLupus Erythematosus, SystemicLipidsVascular StiffnessHumansFemaleMaleMiddle AgedAdultAntirheumatic AgentsAgedBlood PressureCardiovascular Diseases

Substanzen

HydroxychloroquineGlycated HemoglobinLipidsAntirheumatic Agents

Autor:innen und Institutionen

  • Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden.

ORCID-Profile: Bengt Wahlin

Zitieren

APA

Wahlin, B., Braune, A., Jönsson, E., Wållberg-Jonsson, S., & Bengtsson, C. (2024). Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus. PLOS ONE. https://doi.org/10.1371/journal.pone.0312546

Vancouver

Wahlin B, Braune A, Jönsson E, Wållberg-Jonsson S, Bengtsson C. Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus. PLOS ONE. 2024. doi:10.1371/journal.pone.0312546

BibTeX
@article{Wahlin2024,
  author = {Wahlin, Bengt and Braune, Antje and Jönsson, Elias and Wållberg-Jonsson, Solveig and Bengtsson, Christine},
  title = {Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0312546}
}
Kostenlos starten →